Chronic myeloid leukemia (CML) is initiated and maintained by the tyrosine kinase BCR-ABL which activates a number of signal transduction pathways, including PI3K/AKT signaling and consequently inactivates FOXO transcription factors. Here, AKT1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.